Value of SPET/CT image fusion in the assessment of neuroendocrine tumours with 111In-pentetreotide scintigraphy

Revista Espanola de Medicina Nuclear

Volumn 24, Issue 1, 2005, Pages 14-18

  Paula Moreira, A ^a   Hugo Duarte, L ^a   Vieira, F ^a   Joao F ^a   Pedroso De Lima, J ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Anatomic functional imaging; Image fusion; Neuroendocrine tumours; Somatostatin receptor scintigraphy

Indexed keywords

PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; NEUROENDOCRINE TUMOR; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STAGING; TUMOR LOCALIZATION;

EID: 14644419602     PISSN: 02126982     EISSN: None     Source Type: Journal    
DOI: 10.1157/13070352     Document Type: Article

References (9)

1. Pfannenberg AC, Eschmann SM, Horger M, Lamberts R, Vonthein R, Claussen CD, et al. Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasms. Eur J Nucl Med Mol Imaging 2003;30:835-43.
2. 111In-pentetreotide in assessment of Neuroendocrine tumours. Clin Endocrinol 2003;59:565-73.
3. Even-Sapir E, Keidar Z, Sachs J, Engel A, Bettman L, Gaitini D, et al. The New Technology of Combined Transmission and Emission Tomography in Evaluation of Endocrine Neoplasms. J Nucl Med 2001;42:998-1004.
4. 111In-DTPA-D-Phe1- and 123I-Tyr3-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20:716-31.
5. Patton JA, Delbeke D, and Sandler MP. Image Fusion Using an Integrated, Dual-Head Coincidence Camera with X-ray Tube-Based Attenuation Maps. J Nucl Med 2000;41:1364-8.
6. Seregni E, Chiti A, Bombardieri E. Radionuclide imaging of neuroendocrine tumours: biological basis and diagnostic results. Eur J Nucl Med 1998;25:639-58.
7. Chiti A, Fanti S, Savelli G, Romeo A, Bellanova B, Rodari M, et al. Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours. Eur J Nucl Med 1998;25:1396-403.
8. Krenning EP, Kwekkeboom DJ, Pauwels S, Kvols LK, Reubi JC. Somatostatin Receptor Scintigraphy. En: Freeman LM, editor. Nuclear Medicine Annual 1995. New York: Raven Press, 1995; p. 1-50.
9. Keidar Z, Israel O, Krausz Y. SPECT/CT in Tumor Imaging: Technical Aspects and Clinical Applications. Semin Nucl Med 2003;33:205-18.